Provided by Tiger Fintech (Singapore) Pte. Ltd.

ReShape Lifesciences, Inc.

0.3958
+0.086127.80%
Volume:147.61M
Turnover:63.63M
Market Cap:4.46M
PE:-0.03
High:0.4925
Open:0.4615
Low:0.3723
Close:0.3097
Loading ...
Jan 17, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Nov 30, 2023

Major Issues Report

Form 8-K - Current report
Nov 09, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 09, 2023

Major Issues Report

Form 8-K - Current report
Oct 14, 2023

Major Issues Report

Form 8-K - Current report
Oct 06, 2023

Major Issues Report

Form 8-K - Current report
Sep 28, 2023

Correspondence

Form CORRESP - Correspondence
Sep 28, 2023

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Sep 22, 2023

Major Issues Report

Form 8-K - Current report
Sep 12, 2023

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Aug 26, 2023

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Aug 08, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 08, 2023

Major Issues Report

Form 8-K - Current report
Jun 23, 2023

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
May 16, 2023

Major Issues Report

Form 8-K - Current report
May 15, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 26, 2023

Major Issues Report

8-K - Current report
Apr 17, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Apr 13, 2023

Major Issues Report

8-K - Current report
Mar 21, 2023

Major Issues Report

8-K - Current report